Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,959.00
Bid: 1,952.00
Ask: 1,954.00
Change: 20.00 (1.03%)
Spread: 2.00 (0.102%)
Open: 1,940.00
High: 1,971.00
Low: 1,940.00
Prev. Close: 1,939.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 17th Jul 2014 11:07

Antofagasta: Canaccord Genuity cuts target price from 870p to 835p and maintains a hold recommendation.African Minerals: Canaccord Genuity reduces target price from 230p to 170p and keeps a buy recommendation.Ashmore Group: Goldman Sachs downgrades to neutral with a target price of 430p.Barclays: Exane reduces target price from 280p to 225p retaining a neutral rating.BHP Billiton: Goldman Sachs lowers target price from 1820p to 1810p retaining its neutral rating. Canaccord Genuity reduces target price from 2100p to 1935p and keeps a hold recommendation.Big Yellow Group: Morgan Stanley raises target price from 445p to 615p and upgrades from equal-weight to overweight.Central Asia Mining: Canaccord Genuity lowers target price from 200p to 190p retaining its buy recommendation.City of London Investment Group: N+1 Singer raises target price from 220p to 317p and upgrades to buy.Croda International: Barclays reduces target price from 2330p to 2100p and downgrades from equal-weight to underweight.Diageo: JP Morgan cuts target price from 1780p to 1760p and downgrades from neutral to underweight.Drax Group: Citi cuts target price from 750p to 700p downgrading from buy to neutral.EMIS: Panmure Gordon moves target price from 851p to 858p keeping a buy recommendation. N+1 Singer moves target price from 820p to 830p and retains a buy recommendation.International Ferro Metal: Numis places both its target price and its buy recommendation under review.Fesnillo: Deutsche Bank takes target price from 870p to 890p and maintains a hold recommendation. JP Morgan ups target price from 1030p to 1100p and retains an overweight rating.Friends Life Group: Berenberg ups target price from 310p to 330p and keeps a hold recommendation.Gable Holdings: Panmure Gordon moves target from 92p to 105p and retains a buy recommendation.Genel Energy: Canaccord Genuity reduces target price from 1230p to 1100p, while its buy recommendation remains kept.Glencore Xstrata: Goldman Sachs shifts target price from 295p to 300p and stays with its neutral rating.Greene King: JP Morgan reduces target price from 940p to 890p leaving its neutral rating unaltered.Gulf Keystone: Canaccord Genuity shifts target price from 95p to 100p and keeps a hold recommendation.Hikma Pharmaceuticals: UBS raises target price from 1700p to 2000p and upgrades from neutral to buy.Hilton Food Group: Numis cuts target price from 610p to 592p and retains an add rating.ICAP: UBS lowers target price from 330p to 320p and keeps a sell recommendation. Citi cuts target price from 385p to 370p and leaves its neutral rating unchanged.ITV: Investec places both its target price (prev.: 195p) and its hold recommendation under review.Judges Scientific: WH Ireland reduces target price from 2370p to 1550p and stays with its neutral rating.Kazakhmys: Canaccord Genuity shifts target price from 260p to 265p, while downgrading from hold to sell.Lancashire: JP Morgan cuts target price from 744p to 725p and stays with its neutral rating.Oxford Instruments: N+1 Singer reduces target price from 1445p to 1350p and maintains a hold recommendation.Phoenix Group Holdings: Berenberg upgrades from hold to buy with a target price of 750p.Rexam: Deutsche Bank ups target price from 550p to 570p, while downgrading from buy to hold.Ricardo: Oriel places both its target price (prev.: 670p) and its reduce rating under review.Rio Tinto: Goldman Sachs lowers target price from 2530p to 2520p reiterating its strong sell recommendation. JP Morgan ups target price from 4100p to 4150p and stays with its overweight rating. Canaccord Genuity cuts target price from 4200p to 4145p and reiterates a buy recommendation.Royal Mail: Deutsche Bank reduces target price from 587p to 486p and retains a hold recommendation. JP Morgan cuts target price from 765p to 745p and stays with an overweight rating.Thomas Cook Group: Numis reduces target price from 175p to 135p and maintains its hold recommendation.Trinity Exploration & Production: Investec places its target price (prev.: 250p) under review, while keeping a buy recommendation.Tullow Oil: Canaccord Genuity reduces target price from 950p to 850p and stays with its hold recommendation.Weatherly International: Canaccord Genuity lowers target price from 6p to 5p and keeps its buy recommendation.
More News
27 Sep 2021 09:31

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

Read more
27 Sep 2021 09:28

UPDATE 2-Energy stocks, banks lift FTSE 100; Rolls-Royce top performer

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Rolls-Royce jumps on sales of Spain-based ITP, U.S. Air Force contract* Energy stocks track crude oil prices higher* Hikma Pharma gains o...

Read more
27 Sep 2021 08:50

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

Read more
27 Sep 2021 08:16

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

Read more
27 Sep 2021 07:49

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
13 Sep 2021 16:09

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
2 Sep 2021 09:38

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

Read more
27 Aug 2021 12:32

Hikma, Bio-Thera enter exclusive agreement for monoclonal antibody

(Sharecast News) - Bio-Thera Solutions and Hikma Pharmaceuticals have entered into a commercialisation and license agreement to commercialise a monoclonal antibody used for the treatment of Crohn's disease.

Read more
20 Aug 2021 09:46

LONDON BROKER RATINGS: Peel Hunt ups InterContinental Hotels to Hold

LONDON BROKER RATINGS: Peel Hunt ups InterContinental Hotels to Hold

Read more
20 Aug 2021 08:10

LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons

LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons

Read more
17 Aug 2021 09:46

UPDATE 2-Energy, healthcare stocks lift FTSE 100; BHP Group shines

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* UK employment closer to pre-pandemic levels* BHP Group jumps on strong results* PLUS500 gains on robust revenue forecasts* FTSE 100 up 0.3%...

Read more
12 Aug 2021 16:04

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
6 Aug 2021 17:06

LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report

LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.